Fifth Circuit blocks mifepristone by mail, reinstating in-person requirement

The Fifth Circuit Court of Appeals has blocked the FDA's pandemic-era authorization allowing mifepristone to be mailed directly to patients, and neither side's framing tells you what this court actually decided or why it matters that it was this particular court.

Here are the facts. On Friday, the Fifth Circuit issued a nationwide temporary halt to an FDA policy from 2023 that loosened in-person dispensing requirements for mifepristone, one of two drugs used in medication abortion. That policy, adopted during the COVID-19 pandemic, allowed pills to be prescribed via telehealth and delivered by mail. The court required the abortion pill to be dispensed only in-person at clinics. The pill accounts for more than 60% of all abortions performed in the United States healthcare system. The ruling applies nationwide, not just in the Fifth Circuit's jurisdiction, and will almost certainly be appealed to the Supreme Court.

The left is using language like "a right-wing court just moved to choke off abortion by mail" and describing the court as "packed with conservatives." Mother Jones chose "choke off" deliberately. It's a verb that implies deliberate suffocation. NPR and MSNBC frame this as a court "restricting" abortion access. The left is naming the ideological composition of the bench and suggesting the outcome was predetermined by politics rather than law. What the left is omitting: this ruling doesn't ban abortion pills. It doesn't even ban mail delivery of them. It requires in-person dispensing first, which means a single clinic visit rather than a fully remote process. The left is also not mentioning that the FDA's 2023 policy was itself a major expansion from an earlier compromise position, or that the Fifth Circuit didn't invent the in-person requirement from nothing.

The right is calling this "a major legal victory for the pro-life movement" and framing it as the Fifth Circuit ruling that the Biden policy is "likely unlawful." The Daily Wire and Fox News use language that emphasizes the legal reasoning, not the outcome. They describe this as the court stopping a "Biden-era policy" rather than stopping pill access, which is precise language but also selective. What the right is omitting: the in-person requirement was originally put in place in 2000 by the FDA under a Republican administration, and the 2023 loosening was based on two decades of safety data showing remote prescribing posed no unusual risk. The right is not explaining why this particular court, the Fifth Circuit, is hearing this case at the national level instead of it being handled through normal judicial channels.

What both sides are silent about: the Fifth Circuit is not an ordinary appellate court. It covers Texas, Louisiana, and Mississippi. It has no nationwide jurisdiction. That a panel from one regional circuit can issue a nationwide injunction blocking a federal agency's policy is itself the story everyone is avoiding. This is a structural power that has exploded since 2016. Courts have been issuing "nationwide injunctions" with increasing frequency, effectively allowing one judge to overrule federal policy across all 50 states. The abortion pill case is the application, not the disease. Neither side wants to talk about court power because both sides plan to use it when they're winning.

The real headline: A regional appellate court has used procedural mechanisms to block nationwide federal policy on abortion pills, previewing how the Supreme Court may ultimately rule while exposing the institutional imbalance that allows single courts to remake national policy.